ROLE OF PROBIOTICS IN PREVENTION AND TREATMENT OF ANTIBIOTIC-ASSOCIATED DIARRHEA IN CHILDREN
https://doi.org/10.15690/pf.v11i4.1062
Abstract
Numerous scientific studies have proved an important role of microbiota in maintaining adequate functioning of the macroorganism and thrown light upon the various issues associated with functional disturbances. Thus, one of the most common causes of intestinal dysbiosis in children is antibiotic therapy, in the setting whereof antibiotic-associated diarrhea (AAD) associated with, but not limited to, pathological activity of Clostridium difficile byproducts — enterotoxin (toxin A), cytotoxin (toxin B) and intestinal peristalsis-inhibiting protein — may develop. However, there are only few published research data on AAD prevalence in children all over the world, which is why it appears impossible to assess the large scale of the problem. That is why it is absolutely necessary to continuously upgrade perception of the role of normal microbiota, etiological factors inducing pathological alterations thereof and approaches to correction of dysbiotic disorders by various medical specialists. Analysis of the current scientific literature demonstrated that AAD prevalence in children varies from 6.2 to 80% depending on the country. The most common (23%) cause of AAD is associated with amoxicillin/clavulanate intake. Moreover, there are data indicating that the AAD development risk is the highest in under-2 children.
At the same time, there are data on the protective effect of probiotics, especially of the complex drugs containing a balanced
combination of bifidus and lactic bacteria, on microbiota.
About the Author
A. N. SurkovRussian Federation
References
1. Zaprudnov A.M., Mazankova L.N. Mikrobnaya flora kishechnika i probiotiki [Microbial gut flora and probiotics]. Moscow, Pediatriya, 1999. 48 p.
2.
3. Surkov A.N. Tactics of treatment of acute intestinal infections in children. Voprosy sovremennoi pediatrii – Current pediatrics. 2011; 10 (6): 141−47.
4.
5. Mikrobiota pishchevaritel'nogo trakta. Pod red. A.I. Khavkina [Microbiota of the digestive tract. Edited by A.I. Khavkin]. Moscow, Fond sotsial'noi pediatrii. 2006. 416 p.
6.
7. Khavkin A.I. Narusheniya mikroekologii kishechnika. Printsipy korrektsii. Metodicheskie rekomendatsii [Violations microecology intestine. The principles of correction. Methodical recommendations]. Moscow, 2004. 40 p.
8.
9. Kuchumova S.Yu., Poluektova E.A., Sheptulin A.A., Ivashkin V.T. The physiological significance of the intestinal microbiota. Consilium medicum. Gastroenterologiya – Consilium medicum. Gastroenterology. 2011; 2: 75−8.
10.
11. Ursova N.I. Narusheniya mikrobioty i disfunktsii biliarnogo trakta u detei. Pod red. prof. G.V. Rimarchuk [Violations of the microbiota and dysfunction of the biliary tract in children. Edited by prof. G.V. Rimarchuk]. Moscow, 2005. 218 p.
12.
13. Minushkin O.N., Ardatskaya M.D., Zverkov I.V., Chicherin I.Yu. Disbakterioz kishechnika (ponyatie, diagnostika, printsipy lechebnoi korrektsii). Sovremennye vozmozhnosti prebioticheskoi terapii [Intestinal dysbiosis (concept, diagnosis, treatment principles correction). Modern possibilities of prebiotic therapy]. Moscow, 2010. 50 p.
14.
15. Damrongmanee A., Ukarapol N. Incidence of antibiotic-associated diarrhea in a pediatric ambulatory care setting. J Med Asso Thai. 2007; 90: 513−7.
16.
17. Avdeeva T.G., Ryabukhin Yu.V., Parmenova L.P., Krutikova N.Yu., Zhlobnitskaya L.A. Detskaya gastroenterologiya: rukovodstvo [Pediatric Gastroenterology: Guide]. Moscow, GEOTAR-Media, 2011. 192 p.
18.
19. Ursova N.I., Rimarchuk G.V., Shcheplyagina L.A., Savitskaya K.I. Sovremennye metody korrektsii disbioza kishechnika u detei. Uchebnoe posobie [Modern methods of correction of intestinal dysbiosis in children. Textbook]. Moscow, MONIKI, 2000. 48 p.
20.
21. Alam S., Mushtaq M. Antibiotic associated diarrhea in children. Indian Pediatrics. 2009; 46: 491−96.
22.
23. Mitchell D.K., Van R.D., Mason E.H., Norris D.M., Pickering L.K. Prospective study of toxigenic Clostridium difficile in children given amoxicillin/clavulanate for otitis media. Pediatr Infect Dis J. 1996; 15: 514−9.
24.
25. Vanderhoof J.A., Whitney D.B., Antonson D.L., Hanner T.L., Lupo J.V., Young R.J. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999; 135: 564−8.
26.
27. Arvola T., Laiho K., Torkkeli S., Mykkänen H., Salminen S., Maunula L. et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999; 104: e 64.
28.
29. Jirapinyo P., Densupsoontorn N., Thamonsiri N., Wongarn R. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai. 2002; 85 (Suppl. 2): S739−42.
30.
31. Turke D., Bernet J. P., Marx J., Kemph H., Giard P., Welbaum O., Lacombe A., Rembert F., Toursel F., Bernasconi P., Gottrand F., McFarland L.V., Bloch K. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr. 2003; 37: 22−6.
32.
33. La Rosa M., Bottaro G., Gulino N., Gambuzza F., Di Forti F., Inì G. et al. Prevention of antibioticassociated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children: a multicentric double-blind vs. placebo study. Minerva Pediatr. 2003; 55: 447−52.
34.
35. Seki H., Shiohara M., Matsumura T., Miyagawa N., Tanaka M., Komiyama A. et al. Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. Pediatr Int. 2003; 45: 86−90.
36.
37. Kotowska M., Albrecht P., Szajewska H. Saccaromyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo controlled trial. Aliment Pharmacol Ther. 2005; 21: 583−90.
38.
39. Ruszczynski M., Radzikowski A., Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Alimentary Pharmacol Therap. 2008; 28: 154−61.
40.
41. Kramer M.S., Hutchinson T.A., Naimark L., Contardi R., Flegel K.M., Leduc D.G. Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients. Pediatrics. 1985; 76: 365−70.
42.
43. Detskaya gastroenterologiya: rukovodstvo dlya vrachei. Pod red. prof. N. P. Shabalova [Pediatric Gastroenterology: Guide for physicians. Edited by prof. N.P. Shabalova]. Moscow, MEDpress-inform, 2011. 736 p.
44.
45. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006; 101 (4): 812−22.
46.
47. Pinto L.J.F., Alcides A.P.P., Ferreira E.O., Avelar K.E.S., Sabra A., Domingues R.M.C.P. et al. Incidence and importance of Clostridium difficile in paediatric diarrhoea in Brazil. J Med Microbiol. 2003; 52: 1095−9.
48.
49. Benson L., Song X., Campos J., Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol. 2007; 28: 1233−5.
50.
51. Gogate A., De A., Nanivadekar R., Mathur M., Saraswathi K., Jog A. et al. Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhea due to Clostridium difficile in children. Indian J Med Res. 2005; 122: 518−24.
52.
53. Bolezni kishechnika u detei. Pod obshchei redaktsiei A. M. Zaprudnova [Diseases of the intestine in children. Edited by A.M. Zaprudnov]. Moscow, Anakharsis, 2009. 280 p.
54.
55. Ardatskaya M.D., Dubinin A.V., Minushkin O.N. Intestinal dysbiosis: modern aspects of the problem, the principles of diagnosis and treatment. Terapevticheskii arkhiv – Therapeutic archive. 2001; 2: 67−72.
56.
57. Maksimov V.A., Dalidovich K.K., Chernyshev A.L., Mel'nikov V.L. Diagnosticheskie testy pri zabolevaniyakh organov pishchevareniya [Diagnostic tests for diseases of the digestive organs]. Penza, Informatsionno-izdatel'skii PGU, 2005. 228 p.
58.
59. Rimarchuk G.V., Shcheplyagina L.A., Kruglova I.V., Tyurina T.K. Narushenie mikrobioty kishechnika u detei (klinicheskoe znachenie, diagnostika, faktory riska, novye tekhnologii v lechenii). Lektsiya dlya vrachei [Violation of the microbiota of the intestine in children (clinical significance, diagnosis, risk factors, new technologies in the treatment). Lecture for physicians]. Moscow, 2009. 32 p.
60.
61. Kaznacheeva L.F., Ishkova N.S., Kaznacheev K.S., Molokeev A.V. Metody korrektsii disbioticheskikh narushenii kishechnika u detei. Pod red. L.F. Kaznacheevoi [Correction methods dysbiotic bowel disturbances in children. Edited by L.F. Kaznacheeva]. Novosibirsk, 2006. 48 p.
62.
63. Kale-Pradhan P.B., Jassal H.K., Wilhelm S.M. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy. 2010; 30 (2): 119−26.
64.
65. Bergogne-Bеrеzin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents. 2000; 16 (4): 521−6.
66.
67. Doron S.I., Hibberd P.L., Gorbach S.L. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol. 2008; 42 (Suppl. 2): S58−63.
68.
69. Szajewska H., Ruszczyński M., Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006; 149 (3): 367−72.
70.
71. Shenderov B.A. Meditsinskaya mikrobnaya ekologiya i funktsional'noe pitanie. T. 1 [Medical microbial ecology and functional nutrition. Volume I]. Moscow, GRANT"", 1998. 288 p.
72.
73. Bel'mer S.V., Gasilina T.V., Khavkin A.I., Eiberman A.S. Funktsional'nye narusheniya organov pishchevareniya u detei. Rekomendatsii i kommentarii [Functional disorders of the digestive system in children. Recommendations and comments]. Moscow, 2006. 44 p.
74.
75. Tat'yanina O.F. Modern antibiotics: new opportunities in the prevention dysbiotic violations. Voprosy sovremennoi pediatrii – Current pediatrics. 2011; 10 (6): 77−82.
76.
77. Surkov A.N. The possibility of probiotic therapy in treatment of antibiotic-associated diarrhea in children. Voprosy sovremennoi pediatrii – Current pediatrics. 2011; 10 (2): 132−6.
78.
79. Surkov A.N. The possibility of correction and prevention of disorders of intestinal microbiocenosis in sickly children. Voprosy sovremennoi pediatrii – Current pediatrics. 2013; 12 (2): 59−65.
80.
81. Ursova N.I. Antibiotic diarrhea: a choice from the standpoint of probiotic medicine based on evidence. Trudnyi patsient – The difficult patient. 2013; 11 (2−3): 22−8.
82.
83. Li I.A., Sil'vestrova S.Yu., Drozdov V.N. Probiotic Balance RioFlora Neo and therapy of H. pylori - increase the effectiveness of treatment by reducing adverse events. Meditsinskii sovet – Medical advice. 2013; 10: 100−3.
84.
85. Samsonov A.A., Plotnikova E.Yu. Antibiotics: friends or enemies, how to find a consensus? A look at the gastroenterologist of antibiotic. Trudnyi patsient – The difficult patient. 2012; 10 (6): 16−24.
Review
For citations:
Surkov A.N. ROLE OF PROBIOTICS IN PREVENTION AND TREATMENT OF ANTIBIOTIC-ASSOCIATED DIARRHEA IN CHILDREN. Pediatric pharmacology. 2014;11(4):41-45. (In Russ.) https://doi.org/10.15690/pf.v11i4.1062